HOME >> BIOLOGY >> NEWS
Yale licenses potential anti-HIV agent to Oncolys BioPharma of Japan

New Haven, Conn. - Yale University today announced that it has concluded a license agreement granting Oncolys BioPharma, Inc. of Tokyo the global exclusive right for clinical and business development of a novel compound for the treatment of HIV.

A patent application has been submitted by Yale for 2',3'-Didehydro-3'-Deoxy-4'-Ethynylthymidine, or Ed4T, a compound with a new and potentially effective anti-HIV clinical treatment.

Ed4T is a thymidine analogue that blocks HIV-1 reverse transcriptase, the enzyme that is essential for viral replication. The compound was discovered and developed jointly by Professor Masanori Baba of Kagoshima University and Professor Hiromichi Tanaka of Showa University in Japan, and Yung-Chi Cheng, the Henry Bronson Professor of Pharmacology at Yale University School of Medicine.

"This license agreement was possible because Yale has shown keen appreciation of our corporate philosophy -- pharmaceutical development creating timely remedies for maximum patient relief," said Yasuo Urata, President and CEO of Oncolys BioPharma. "We will give this project our concentrated effort so that patients worldwide can have the benefit of 'Ed4T'as soon as possible." Pre-clinical studies have already begun and Oncolys BioPharma will accelerate the studies with a target of initiating Phase I/II clinical trials in 2008.

An estimated 20 million people worldwide have died from AIDS and 40.3 million are infected with the virus. In 2004, a reported 1,000 patients in Japan were infected -- and the numbers are rapidly increasing.

"Yale is very proud of the contribution it makes to fighting the HIV pandemic though discovery of novel antiviral drugs," stated E. Jonathan Soderstrom, Managing Director of the Yale Office of Cooperative Research, which is responsible for licensing technologies on behalf of Ya
'"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
27-Jun-2006


Page: 1 2 3

Related biology news :

1. University of Colorado licenses two influenza virus detection discoveries to Quidel Corp.
2. Rensselaer licenses microscope technology to Thorlabs
3. Columbia University licenses next-generation DNA sequencing technology
4. Case Western Reserve University licenses methoxyamine to Tracon
5. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
6. Bayer HealthCare licenses Genomatix for microarray analysis
7. Isotron licenses ORNL cancer treatment technology
8. IC-medtech licenses promising cancer therapeutic from Summa Health System
9. UCF research links proteins, stem cells and potential Alzheimers treatment
10. Picky eating potentially perilous for bats
11. Scientists take next step in understanding potential target for ovarian cancer treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2018)... , ... September 20, 2018 , ... ... version of NovoExpress® software which supports the recently launched NovoCyte ... NovoCyte® flow cytometer and NovoSampler® Pro products. , In addition ...
(Date:9/15/2018)... ... 14, 2018 , ... Today, Mediaplanet announces the launch of ... being done within rare diseases research, diagnostics, and will highlight what industry experts ... , The print component of "Rare Diseases" is distributed within ...
(Date:9/7/2018)... ... September 05, 2018 , ... Following ... manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have ... cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the ...
Breaking Biology News(10 mins):
(Date:8/29/2018)... Calif. (PRWEB) , ... August 28, 2018 , ... ... scientists from around the world, is proud to announce the launch of a new ... offers for a chance to win one of LabRoots most popular shirts. , Throughout ...
(Date:8/23/2018)... , ... August 22, 2018 , ... ... for Android on September 1st, making it the first fully-featured app for electronic ... Android devices. Combined, iOS and Android constitute 99 percent of the market share ...
(Date:8/17/2018)... ... , ... The opening of the new Titusville facility marks the completion of ... had a well established local presence, servicing the Space Coast since 1972. Astro Pak ... ongoing work at the Mobile Launch Platform (MLP) in support of NASA’s upcoming Space ...
(Date:8/14/2018)... ... 2018 , ... Labconco Corporation manufactures laboratory equipment, specializing in ... Labconco produces other lab equipment, such as glassware washers and freeze dryers. Labconco ... in design and manufacturing. , Through this webinar, which is sponsored by ...
Breaking Biology Technology:
Cached News: